期刊文献+

同步放化疗联合射频消融术治疗非小细胞肺癌的临床观察 被引量:12

Combination of synchronization chemoradiotherapy and CT-guided radiofrequency ablation for treatment of non-small cell lung cancer
原文传递
导出
摘要 目的:探讨同步放化疗联合射频消融术治疗非小细胞肺癌的临床疗效。方法:将40例非小细胞肺癌患者随机分为放化疗联合射频消融术(综合组,n=19)和单纯放化疗(对照组,n=21)。化疗采用常规EP方案,放疗为适形放疗。分别于治疗完成后3、6个月和1、2、3年复查,从KPS、肿瘤大小、生存率对患者进行临床评价,研究综合治疗的临床疗效。结果:综合治疗的KPS评分及肿瘤体积减小明显高于对照组,且差异有统计学意义,P<0.05。有效率(CR+PR)综合组为78.9%,而对照组为42.9%。综合组6个月、1、2和3年生存率分别约为100.0%(19/19)、89.4%(17/19)、73.6%(14/19)和57.9%(11/19);对照组分别为100%(21/21)、76.2%(16/21)、47.6%(10/21)和28.6%(6/21),3年生存率差异有统计学意义,P=0.03。结论:放化疗联合射频消融治疗非小细胞肺癌能显著增强疗效,提高患者生存率,是目前较理想、值得临床广泛推广的一种综合治疗方法。 OBJECTIVE:To discuss the clinical curative effect combination of synchronization chemoradiotherapy and CT-guided radiofrequency ablation for treatment of non-small cell lung cancer.METHODS:Forty non-small cell lung cancer patients were involved in this study.Nineteen recieved combination of synchronization chemoradiotherapy and CT-guided radiofrequency ablation(the synthesis group),and 21 recieved the synchronization chemoradiotherapy(the control group 21).The chemotherapy was the conventional EP plan,and the radiotherapy was three-dimensional conformal radiotherapy.The patients were asked to come back to hospital for check 3 months,6 months,1 year,2 years and 3 years after treatment respectively.And the clinical evaluation were performed from KPS,tumor size and survival rate.RESULTS:KPS grading and the tumor volume reduce in synthesis group were higher than the control group obviously,and had the remarkable statistics significance(P〈0.05).Effectiverates(CR+PR) were 78.9% and 42.9%.Six months,1-,2-and 3-years survival rates were 100%(19/19),89.4%(17/19),73.6%(14/19),57.9%(11/19) in synthesis group;In the control group,they were 100%(21/21),76.2%(16/21),47.6%(10/21),28.6%(6/21);Three year survival rates had the remarkable statistics significance(P=0.03).CONCLUSION:Combination the synchronization chemoradiotherapy and CT-guided radiofrequency ablation for the treatment of non-small cell lung cancer,can obviously strengthen the treat ment effect,raise the patient survival rate.It is worth clinical widespread.
出处 《中华肿瘤防治杂志》 CAS 2011年第23期1870-1873,共4页 Chinese Journal of Cancer Prevention and Treatment
基金 山东省济宁市科技攻关项目(201085Ⅱ-16)
关键词 非小细胞肺/药物疗法 非小细胞肺/放射疗法 射频消融 联合 carcinoma non-small cell lung/drug therapy carcinoma non-small cell lung/radiotherapy radiofrequency ablation combination
  • 相关文献

参考文献10

二级参考文献50

  • 1张福刚,田呈祥.肺癌介入治疗的进展[J].医疗设备信息,2004,19(5):38-40. 被引量:3
  • 2郭颖,乔正荣.射频消融治疗恶性肿瘤现状[J].中华肿瘤防治杂志,2006,13(9):703-706. 被引量:18
  • 3李勇,张湘茹,孙燕.非小细胞肺癌的化疗进展[J].癌症进展,2006,4(4):333-341. 被引量:40
  • 4吴一龙,廖美琳,蒋国墚,等.肺癌诊断治疗临床指引(2003年版)[Z].中国抗癌协会肺癌专业委员会.
  • 5Non - small Cell Lung Cancer Collaborative Group . Chemotherapy in non- small cell lung cancer :a metaanalysis using updated individual patiene date from 52 randomised clinical triacs[ J]. Br Med J ,1995,311 (7) :899 -909.
  • 6Rowell NP, Orourke NP. Concurrent chemoradiotherapy in non -small cell lung cancer (review)[ J ]. The Cochraue Library ,2005, Issue 1.
  • 7Lilenbaum RC , Language P, Dickersin K. Single agent versus combination chemotherapy in patienes with advanced non - small cell lung carcinoma [ J]. Cancer, 1998,86 : 116.
  • 8Hoang T, Scuiller JH. Advanced Nsclc : From cytotoxic systemic chemotuerapy to molecularly targeted therapy [ J ]. Expere Rev Aueicancer Ther,2002,2:393.
  • 9Berthaud P, Le Chevalier T, Ruffice P, et al. Phase Ⅰ - Ⅱ study of navecbline (vinorellbine) plus cisplatin in advanced non - small cell lung cancer[ J]. Eur Cancer, 1992,28 (A) : 1863.
  • 10Sun Yan, Shi Yuan Kai. Manual medical oncology [ M ]. Beijing People' s Medical Publishing House,2007:7 414.

共引文献40

同被引文献128

引证文献12

二级引证文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部